Top compounds associated with response to TMEM74


Feature Type Standardized
Nominal ANOVA
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.18 5e-09
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.17 7e-09
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.17 1e-08
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.18 2e-08
mRNA parbendazole CTRPv2 pan-cancer AAC 0.17 2e-08
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA BRD1812 CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.19 3e-08
Download CSV